Treatment guidelines for chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune neuro-muscular condition impacting the myelin that insulates and protects peripheral nerves causing mobility and sensory impairment, have been in place for many years with new treatment approvals being scarce. Newly …
Crohn’s disease (CD) can cause progressive bowel damage, impaired quality of life, and permanent disability. Severity and presentation can vary widely from person to person, necessitating an individualized treatment approach. The use of more readily available imaging modalities such as …
Cytokines, such as interleukin (IL)-23, are key drivers of intestinal inflammation in patients with inflammatory bowel disease. While all IL-23–targeted agents neutralize IL-23, differences in antibody structure can improve the ability of these agents to capture this inflammatory cytokine from …
Recent advances in the treatment of gynecologic cancers are promising, and education is needed to ensure that both oncology and primary care clinicians, including OB/GYNs, have a thorough knowledge of biomarkers, current and emerging therapies, and how the latest clinical …
Health inequities in oral health care significantly impact underserved and minority populations, leading to disparities in diagnosis, treatment, and outcomes. Studies have shown that racial and ethnic minorities often receive lower quality dental care, face higher rates of oral diseases, …
With this CME Outfitters Briefcase activity, we will delve into a patient case interaction, set in a primary care/women’s health setting, to explore critical concepts in migraine management. Despite advancements, unmet needs persist for patients with migraine, especially among women, …
In this CME Outfitters Briefcase activity, we will examine a patient case interaction within an emergency department (ED) setting to explore critical concepts in migraine management. Despite advancements, unmet needs persist for patients with migraine, particularly among women, marginalized communities, …
Treatment guidelines for chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune neuro-muscular condition impacting the myelin that insulates and protects peripheral nerves causing mobility and sensory impairment, have been in place for many years with new treatment approvals being scarce. Newly …
Biomarker or molecular testing to help oncologists match patients with the best cancer treatment can be challenging in the community oncology setting and for patients in underserved communities. At present, patients with cancer in racially or ethnically underserved communities are …